Preferred Label : MVA Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP;
NCIt synonyms : Modified Vaccinia Virus Ankara Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP; Modified Vaccinia Ankara Tumor-specific Neoantigen Boosting Vaccine MVA-209-FSP;
NCIt definition : An off-the-shelf neoantigen boosting vaccine comprised of a modified Vaccinia virus
Ankara (MVA) encoding tumor-specific neoantigens (TSNAs) derived from the same as
of yet undisclosed frameshift peptides (FSPs) targeted by the priming vaccine, great
ape adenoviral tumor-specific neoantigen priming vaccine GAd-209-FSP, with potential
immunostimulatory and antineoplastic activities. Following intramuscular administration
of the priming vaccine GAd-209-FSP, the booster MVA tumor-specific neoantigen boosting
vaccine MVA-209-FSP may serve to further expand and improve the phenotyping of antigen-specific
T-cells targeted to the tumor cells expressing the TSNAs.;
Molecule name : MVA-209-FSP;
NCI Metathesaurus CUI : CL973172;
Origin ID : C162806;
UMLS CUI : C5206829;
Semantic type(s)
- concept_is_in_subset
